Thriva Health
Thriva Health is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Thriva Health.
Thriva Health is a company.
Key people at Thriva Health.
Key people at Thriva Health.
Thriva Health is a UK-based healthtech company offering at-home blood testing kits and personalized health insights to empower proactive health management.[1][2] It serves consumers directly through subscription-based testing and B2B partners like the NHS, insurers, and GPs, solving the problem of inaccessible, reactive healthcare by enabling real-time tracking of biomarkers to prevent chronic diseases and reduce NHS pressure.[1][3][4] With over 2 million people helped since launch, Thriva has gained strong growth momentum, including CQC registration for expanded venous testing and a Thriva+ membership model with consultations.[3]
Thriva was co-founded in 2015 (with operations starting in 2016) by Hamish Grierson (CEO), Tom Livesey, and Eliot Brooks, all with finance backgrounds who spotted opportunities to disrupt healthcare like they did in fintech.[2][4] The idea emerged when Brooks shared his blood results showing familial hypercholesterolaemia; the group recognized the value in blood data but frustration with slow, unhelpful delivery, inspiring a consumer-friendly platform for self-management.[4] Early traction came from launching finger-prick home tests, attracting over 200,000 customers initially, and later expanding with Sarvi Eastell as Chief Medical Officer, a surgeon who joined after initially critiquing the product.[1][4] Pivotal moments include MHRA-approved AI for personalized recommendations and CQC registration in 2023 for clinical credibility.[2][3]
Thriva rides the preventative healthtech wave, leveraging at-home diagnostics, AI personalization, and bio-data to shift from reactive NHS treatment to upstream intervention amid rising chronic disease burdens.[2][3][4] Timing aligns with post-pandemic demand for accessible health tools and NHS strains, where self-testing cuts GP visits and enables triaging.[4] Favorable market forces include regulatory nods (CQC, MHRA) enabling scale, plus B2B integrations with public/private health systems.[3] It influences the ecosystem by normalizing blood tracking, fostering data-driven behaviors, and partnering to alleviate healthcare pressures, paving the way for broader adoption of consumer-led diagnostics.[1][3]
Thriva is poised to expand Thriva+ memberships with more consultations and venous/home services, deepening B2B ties with NHS/insurers for nationwide impact.[3] Trends like AI advancements, wearable integration, and personalized medicine will accelerate its mission, potentially evolving into a full preventative platform reducing chronic disease incidence.[2][3] As it scales from 2 million users, Thriva could redefine proactive health, making bio-data as routine as fitness trackers and easing systemic burdens—empowering individuals from the first test onward.[1]
